Infectious complications in neutropenic cancer patients

被引：10
作者：
Menichetti, Francesco [1 ]
机构：
[1] Nuovo Osped, Azienda Osped Univ Pisana, Pisa, Italy
来源：
INTERNAL AND EMERGENCY MEDICINE | 2010年 / 5卷
关键词：
Cancer; Neutropenia; Infectious complications; PREEMPTIVE ANTIFUNGAL THERAPY; HIGH-RISK; PROPHYLAXIS; FEVER;
D O I：
10.1007/s11739-010-0456-8
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Cancer patients are at risk of infectious complications due to neutropenia following chemotherapy or early post-HSCT (Hemato Stem Cell Transplantation). The first episode of fever during recent onset neutropenia is caused mostly by bacteria, while subsequent episodes are mainly fungal in nature. Proper management of infectious complications in neutropenic cancer patients requires classification into the appropriate risk category and knowledge of the local epidemiology of infections, of the causative organisms and their resistance phenotype.
引用
收藏
页码：S21 / S25
页数：5
相关论文
共 50 条
  • [41] Cefepime versus ceftazidime as empiric therapy for fever in neutropenic patients with cancer
    Chandrasekar, PH
    Arnow, PM
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (09) : 989 - 995
  • [42] Emergency department disposition of non-neutropenic febrile patients with cancer
    Bischof, Jason J.
    Sylvester, Patrick J.
    Frey, Jennifer A.
    Stephens, Julie A.
    Hammond, Becca
    Garmatter, Joshua
    Hebert, Courtney
    Caterino, Jeffrey M.
    JOURNAL OF THE AMERICAN COLLEGE OF EMERGENCY PHYSICIANS OPEN, 2021, 2 (05)
  • [43] THE SURGICAL CHOICE IN NEUTROPENIC PATIENTS WITH HEMATOLOGICAL DISORDERS AND ACUTE ABDOMINAL COMPLICATIONS
    CHIRLETTI, P
    BARILLARI, P
    SAMMARTINO, P
    CARDI, M
    CARONNA, R
    ARCESE, W
    PETTI, C
    STIPA, V
    LEUKEMIA & LYMPHOMA, 1993, 9 (03) : 237 - 241
  • [44] Pneumonia in the neutropenic cancer patient
    Evans, Scott E.
    Ost, David E.
    CURRENT OPINION IN PULMONARY MEDICINE, 2015, 21 (03) : 260 - 271
  • [45] Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients?
    Shomali, William
    Hachem, Ray
    Chaftari, Anne-Marie
    Jiang, Ying
    Bahu, Ramez
    Jabbour, Joseph
    Raad, Sammy
    Al Shuaibi, Munirah
    Al Wohoush, Iba
    Raad, Issam
    CANCER, 2012, 118 (23) : 5823 - 5829
  • [46] Optimal Management of Neutropenic Fever in Patients With Cancer
    Zimmer, Andrea J.
    Freifeld, Alison G.
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (01) : 19 - +
  • [47] Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients
    Nijhuis, CSMO
    Vellenga, E
    Daenen, SMGJ
    van der Graaf, WTA
    Gietema, JA
    Groen, HJM
    Kamps, WA
    de Bont, ESJM
    INTENSIVE CARE MEDICINE, 2003, 29 (12) : 2157 - 2161
  • [48] Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients
    Claudi S. M. Oude Nijhuis
    Edo Vellenga
    Simon M. G. J. Daenen
    Winette T. A. van der Graaf
    Jourik A. Gietema
    Harry J. M. Groen
    Willem A. Kamps
    Eveline S. J. M. de Bont
    Intensive Care Medicine, 2003, 29 : 2157 - 2161
  • [49] Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours
    Marin, Mar
    Gudiol, Carlota
    Ardanuy, Carmen
    Garcia-Vidal, Carol
    Calvo, Mariona
    Arnan, Montserrat
    Carratala, Jordi
    JOURNAL OF INFECTION, 2014, 69 (05) : 417 - 423
  • [50] Risk stratification in febrile neutropenic episodes in adolescent/young adult patients with cancer
    Phillips, Robert S.
    Bhuller, Kaljit
    Sung, Lillian
    Ammann, Roland A.
    Tissing, Wim J. E.
    Lehrnbecher, Thomas
    Stewart, Lesley A.
    EUROPEAN JOURNAL OF CANCER, 2016, 64 : 101 - 106
12345